The Burrill Report
Download your complimentary copy of the January 2012 issue of The Burrill Report .
News
Biotech Dealmaking Gets off to a Strong Start in 2012 February 01, 2012 | Press Release
Burrill & Company Announces Close of Burrill Brazil Fund I January 18, 2012 | Press Release
David Wetherell Joins Burrill & Company Venture Capital Group as Managing Director January 06, 2012 | Press Release
See all News
Paul Freiman
Venture Partner, BrazilOver 40 years of experience in founding and management of biotechnology and healthcare companies. Mr. Freiman, former CEO of Syntex, led the company through its acquisition by Roche Holdings in $5.3 billion transaction. He has been chairman of the Pharmaceutical Manufacturers of America Association (PhRMA) and has also chaired a number of key PhRMA committees both domestic and international. He served as CEO of a biotech firm based in California. He serves on three biotechnology Boards as well as that of a Major Japanese Company.
Currently domiciled in Rio de Janeiro, Mr. Freiman has extensive experience in Latin America, having also served as Vice President Latin America.